PATENT CLAIM ANALYSIS

Application Number: 15887684
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "457000"]

Abstract:
The present invention provides a novel therapeutic combination comprising one or more anti-androgen agents and one or more antibiotic/anti-inflammatory agents or pharmaceutically acceptable salts or hydrates thereof, useful for the treatment of a dermatological disorder.

Claim (Index 7):
The composition of  claim 2  comprising spironolactone, 4\u2032,7-isoflavandiol, and doxycycline monohydrate.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 88.0
- Lexical Diversity: 1.23333
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13518818', '14157754', '10272499', '11223433', '11876478']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7059571071817072
- 35 USC 102 Novelty (BERT): 0.5319386394574608
- Combined Prediction Score: 0.6885552604092826
- Mean Citation Score: 236.664152
- Max Citation Score: 334.4243
- Similarity Product: 238.4689638947428

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test